Close

News

BCG vaccine safe for elderly, can protect against respiratory infections

The BCG vaccine, which is frequently given to children to prevent tuberculosis, is safe to give to the elderly, and can protect them against various infections, according to a study which says it may have a broad, stimulating effect...

Ohio State University researchers working on promising COVID-19 vaccine

An experimental vaccine under research at The Ohio State University has shown the potential to be an option moving forward in the quest to stamp out COVID-19. Researchers have used an engineering technique that allows for manipulation of the messenger...

Johnson & Johnson Announces Agreement in Principle with Government of Canada to Supply its COVID-19 Vaccine Candidate

Janssen Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, has agreed in principle to supply the Government of Canada with doses of its SARS-CoV-2 vaccine candidate, Ad26.COV2.S. The availability of the vaccine candidate is subject to...

Thermo Fisher Scientific Officially Opens New Site for Manufacturing COVID-19 Sample Collection Products

Thermo Fisher Scientific Inc., the world leader in serving science, officially cut the ribbon on its new $40 million facility in Lenexa, Kansas dedicated to viral transport media (VTM) production. The company is also announcing that the site will...

CSafe Global Expands Further into Asia Opening Hub Operations in Taipei, Taiwan

CSafe Global, the innovation leader in temperature-controlled container solutions for the transport of life-enhancing pharmaceuticals, has once again expanded their global reach and local presence with the opening of a new hub operation in Taipei, Taiwan. This new addition to...

Stevanato Group signs an agreement with Nelson Labs to provide best-in-class Extractables & Leachables testing services at its US Technology Excellence Center

Italian-based Stevanato Group, a leading producer of glass primary packaging and provider of integrated services for combination products, and Nelson Laboratories, LLC, a global provider of lab testing and expert advisory services signed  a partnership agreement that will provide...

EU approves AstraZeneca’s Imfinzi for treatment of extensive-stage small cell lung cancer

AstraZeneca’s Imfinzi (durvalumab) has been approved in the European Union for the first-line treatment of adults with extensive-stage small cell lung cancer (ES-SCLC) in combination with a choice of chemotherapies, etoposide plus either carboplatin or cisplatin. SCLC is a highly...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read